Skip to content
October 19, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Asro October 18, 2026 8 minutes read
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness-5

NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from "early detection" to the stark, often-overlooked reality of those living with Stage 4 disease. On October 13, 2026—National Metastatic Breast Cancer Awareness Day—more than 325 landmarks across 50 U.S. states and 20 countries will be bathed in teal, green, and pink.

This coordinated display, spearheaded by METAvivor Research and Support, marks the centerpiece of the #LightUpMBC campaign. The initiative aims to illuminate the truth about metastatic breast cancer (MBC), a disease that remains incurable and claims the lives of approximately 117 people in the United States every single day. By turning the sky into a canvas of advocacy, organizers hope to drive significant funding toward the only thing that can change the prognosis for Stage 4 patients: dedicated scientific research.

Main Facts: A Global Visual Statement

The #LightUpMBC campaign is a massive logistical undertaking involving 195 cities worldwide. From the towering heights of the One World Trade Center in New York City and the Willis Tower in Chicago to international sites like the Mactan-Cebu Airport in the Philippines and the Ness Bridge in Scotland, the world’s most recognizable structures will participate.

The color palette of the illumination is deeply symbolic. While the traditional pink ribbon has become the universal symbol for breast cancer, the MBC community utilizes a tri-color scheme:

  • Teal: Represents healing and spirituality.
  • Green: Symbolizes the triumph of spring over winter, renewal, and life.
  • Pink: Acknowledges the origins of the disease in the breast.

The primary objective of the 2026 campaign is twofold: to provide a visual tribute to the lives lost to the disease and to serve as a massive fundraising engine. METAvivor, the non-profit behind the movement, is unique in its commitment to funding research exclusively for Stage 4 breast cancer. In an era where much of breast cancer philanthropy is directed toward screening and early-stage prevention, METAvivor fills a critical gap by focusing on the patients for whom "early detection" is no longer a solution.

Accompanying the physical illuminations is #LightUpMBC Live, a virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT on October 13. This free-to-stream event will blend patient testimonials with scientific updates and high-caliber musical performances, creating a global town hall for the MBC community.

Chronology: From a Single Bridge to a Global Phenomenon

The origins of #LightUpMBC are rooted in a personal promise and a singular act of friendship. The movement was founded by Laura Inahara in honor of her best friend, Jessica Moore, who was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later.

  • 2017: Jessica Moore expressed a wish to see a local landmark lit in the MBC colors to bring attention to the disease. In her memory, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to "Light Up MBC."
  • 2018–2020: The campaign saw organic growth as patient advocates in other states began petitioning their local governments and building owners. The movement transitioned from a regional tribute to a national awareness day event.
  • 2021–2025: The campaign expanded internationally. Landmarks in Canada, the United Kingdom, and Ireland joined the roster. During this period, the #LightUpMBC Live broadcast was established to bridge the gap between the physical lights and the digital audience. To date, the campaign has raised over $2.7 million for research.
  • 2026: The current year marks the largest iteration of the event in history, with over 325 landmarks confirmed. The campaign has evolved into a sophisticated advocacy platform that integrates social media, live-streamed entertainment, and high-level scientific discourse.

Supporting Data: The Harsh Reality of Stage 4

The urgency of the #LightUpMBC campaign is underscored by sobering statistics provided by the National Cancer Institute and the American Cancer Society.

Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the bloodstream or lymphatic system to other parts of the body—most commonly the bones, liver, lungs, or brain. Despite advances in medical technology, once breast cancer reaches Stage 4, it is considered terminal.

According to 2026 projections, an estimated 42,670 people in the United States will die from breast cancer this year. Virtually all of these deaths are the result of metastatic disease. While the five-year survival rate for localized breast cancer is nearly 99%, that number drops precipitously to approximately 30% for those diagnosed with distant metastatic disease.

A significant point of contention within the advocacy community is the "funding gap." Historical data suggests that while billions of dollars are raised annually for breast cancer, only an estimated 2% to 5% of those funds are traditionally directed toward research for metastatic disease. This disparity is what METAvivor seeks to rectify. By ensuring that 100% of net proceeds go directly to Stage 4 research grants, the organization has become a lifeline for scientists looking for ways to stop the spread of cancer or manage it as a chronic, rather than terminal, condition.

Official Responses: Leadership and Advocacy Perspectives

The leadership of METAvivor emphasizes that while the lights are beautiful, the mission is profoundly serious.

Dr. Kelly Shanahan, a physician and the Board President of METAvivor, has lived with MBC since 2013. Her perspective is both professional and deeply personal. "When I was diagnosed, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days as we look for the next breakthrough. #LightUpMBC is the biggest contributor to this research and is a way to bring us together as a community."

Laura Inahara, the founder of the campaign, reflects on the legacy of Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."

Tami Eagle Bowling, the campaign director and host of the live broadcast, has been living with MBC for 11 years. She notes that the 2026 broadcast will feature an unprecedented lineup of talent to draw in a wider audience. "We have Broadway stars like Kara Lindsay and Victoria Clark joining us because they understand that awareness without action isn’t enough. We need the world to see the faces behind the statistics."

Implications: Changing the Future of Cancer Treatment

The #LightUpMBC campaign represents a shift in how the public perceives breast cancer. For decades, the focus has been on "the cure," often framed as a finish line that patients cross after surgery and chemotherapy. The #LightUpMBC movement challenges this narrative by highlighting the "forever patients"—those for whom treatment never ends.

The implications of this advocacy are far-reaching:

1. Redefining "Success" in Oncology:
The funding provided by METAvivor is fueling research into "stable disease." For many in the MBC community, the goal is to transform Stage 4 cancer into a manageable chronic illness, similar to HIV/AIDS or Type 1 diabetes, where patients can maintain a high quality of life for decades.

2. Patient-Led Research Advocacy:
METAvivor employs a unique review process where patient advocates sit alongside scientific peers to evaluate grant applications. This ensures that the research being funded is aligned with the actual needs and priorities of the people living with the disease.

3. Global Solidarity and Mental Health:
The psychological impact of living with a terminal diagnosis is profound. Events like #LightUpMBC provide a sense of visibility to a population that often feels "erased" by the upbeat, survivor-focused messaging of traditional Breast Cancer Awareness Month. Seeing a landmark in one’s own city glow in teal, green, and pink serves as a powerful reminder that they are not alone.

4. Economic Impact of Research:
By raising millions for research, the campaign is also supporting the scientific infrastructure. The grants awarded by METAvivor often provide the "seed money" that allows researchers to gather enough data to apply for larger federal grants from the National Institutes of Health (NIH).

As October 13 approaches, the organizers of #LightUpMBC are calling on the public to do more than just watch the lights. They are encouraged to take photos, share them on social media with the hashtag #LightUpMBC, and donate to the research fund. In a world that often turns a blind eye to the end-stage realities of cancer, these 325 landmarks will stand as a luminous demand for a different future—one where Stage 4 is no longer a death sentence, but a condition that can be lived with, and eventually, overcome.


How to Participate:

  • Watch: #LightUpMBC Live airs Oct. 13 at 8 p.m. ET on METAvivor’s YouTube and Facebook channels.
  • Locate: A full list of participating landmarks can be found at www.lightupmbc.org.
  • Donate: 100% of net proceeds benefit metastatic breast cancer research.

About the Author

Asro

Author

View All Posts

Post navigation

Previous: A New Era in Oncology: Karen and Rob Hale Commit Record-Breaking $50 Million to Breast Cancer Research Foundation
Next: Navigating the Nexus: GLP-1 Medications and Breast Cancer – An Evolving Landscape

Related Stories

navigating-the-nexus-glp-1-medications-and-breast-cancer-what-the-science-says-1
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says

Pevita Pearce October 18, 2026
a-global-beacon-of-hope-over-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: Over 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Raul Delapena Setiawan October 18, 2026
a-new-era-in-oncology-karen-and-rob-hale-commit-historic-50-million-to-revolutionize-breast-cancer-research-1
  • Patient Advocacy and Support

A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Laily UPN October 18, 2026

Recent Posts

  • Unmasking a Malignant Alliance: How Aggressive Breast Cancer Hijacks the Immune System to Fuel its Growth
  • MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says
  • A Global Beacon of Hope: Over 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Revolutionize Breast Cancer Research

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unmasking-a-malignant-alliance-how-aggressive-breast-cancer-hijacks-the-immune-system-to-fuel-its-growth
  • Medical Research and Clinical Trials

Unmasking a Malignant Alliance: How Aggressive Breast Cancer Hijacks the Immune System to Fuel its Growth

Evan Lee Salim October 18, 2026
macrogenics-initiates-phase-i-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-2
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Rifan Muazin October 18, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-what-the-science-says-1
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says

Pevita Pearce October 18, 2026
a-global-beacon-of-hope-over-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness
  • Patient Advocacy and Support

A Global Beacon of Hope: Over 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Raul Delapena Setiawan October 18, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.